Hart Daniel Ryan's Insider Trades & SAST Disclosures
Hart Daniel Ryan's most recent trade in Avid Bioservices Inc was a trade of 1,755 Common Stock, $0.001 par value done at an average price of $6.1 . Disclosure was reported to the exchange on Dec. 31, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Hart Daniel Ryan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Other type of transaction at price $ 6.05 per share. | 31 Dec 2024 | 1,755 | 112,735 (0%) | 0% | 6.1 | 10,621 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Hart Daniel Ryan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Dec 2024 | 45,328 | 133,793 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Ryan Daniel Hart | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 22,818 | 116,816 | - | - | Performance Stock Units (FY 2025 Grant) | |
| Avid Bioservices Inc | Ryan Daniel Hart | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 22,817 | 139,634 | - | - | Performance Stock Units (FY 2025 Grant) | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.22 per share. | 25 Dec 2024 | 20,845 | 110,980 (0%) | 0% | 12.2 | 254,726 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Hart Ryan | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 11,304 | 162,451 | - | - | Performance Stock Units (FY 2024 Grant) | |
| Avid Bioservices Inc | Ryan Hart Daniel | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 11,303 | 173,755 | - | - | Performance Stock Units (FY 2024 Grant) | |
| Avid Bioservices Inc | Ryan Hart Daniel | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 11,208 | 185,058 | - | - | Performance Stock Units (FY 2023 Grant) | |
| Avid Bioservices Inc | Daniel Hart Ryan | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 11,208 | 196,266 | - | - | Performance Stock Units (FY 2023 Grant) | |
| Avid Bioservices Inc | Ryan Hart Daniel | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 4,279 | 123,096 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Ryan Hart Daniel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Dec 2024 | 4,279 | 88,465 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Hart Ryan Daniel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.22 per share. | 25 Dec 2024 | 1,968 | 131,825 (0%) | 0% | 12.2 | 24,049 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2024 | 136,905 | 265,773 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2024 | 68,452 | 127,375 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Other type of transaction at price $ 5.41 per share. | 28 Jun 2024 | 1,965 | 84,186 (0%) | 0% | 5.4 | 10,623 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 30 Apr 2024 | 2,826 | 82,221 (0%) | 0% | 7.4 | 20,910 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 2,120 | 85,047 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 2,120 | 58,923 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 2,102 | 61,043 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 2,102 | 82,927 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 1,520 | 80,825 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 1,520 | 63,145 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Hart Ryan Daniel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.17 per share. | 09 Jan 2024 | 2,408 | 79,305 (0%) | 0% | 6.2 | 14,857 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Ryan Hart Daniel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 2,119 | 64,665 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Hart Daniel Ryan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 2,119 | 81,713 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 2,101 | 66,784 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Ryan Daniel Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 2,101 | 79,594 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Hart Ryan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 1,520 | 68,885 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Hart Daniel Ryan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 1,520 | 77,493 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Other type of transaction at price $ 5.52 per share. | 29 Dec 2023 | 892 | 75,973 (0%) | 0% | 5.5 | 4,928 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 10,723 | 75,143 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 5,867 | 76,146 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 4,856 | 82,013 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.86 per share. | 10 Jul 2023 | 3,763 | 71,380 (0%) | 0% | 13.9 | 52,153 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2023 | 67,822 | 128,868 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2023 | 33,911 | 90,490 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2023 | 3,621 | 65,689 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2023 | 2,101 | 88,389 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2023 | 1,520 | 86,869 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.77 per share. | 09 Jul 2023 | 1,269 | 64,420 (0%) | 0% | 13.8 | 17,475 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Other type of transaction at price $ 11.46 per share. | 30 Jun 2023 | 927 | 62,068 (0%) | 0% | 11.5 | 10,622 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2023 | 2,102 | 56,579 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2023 | 2,102 | 49,829 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2023 | 1,520 | 47,727 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2023 | 1,520 | 58,681 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.80 per share. | 09 Apr 2023 | 1,280 | 48,549 (0%) | 0% | 19.8 | 25,340 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 14 Mar 2023 | 3,000 | 46,957 (0%) | 0% | 19 | 57,000 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 14 Mar 2023 | 2,000 | 46,957 (0%) | 0% | 19 | 38,000 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.66 per share. | 14 Mar 2023 | 2,000 | 48,957 (0%) | 0% | 5.7 | 11,320 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2023 | 2,000 | 230,380 | - | - | Stock Option(right to buy) | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 2,101 | 51,456 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 2,101 | 60,201 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 1,520 | 62,302 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 1,520 | 49,355 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.44 per share. | 09 Jan 2023 | 1,499 | 49,957 (0%) | 0% | 14.4 | 21,647 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Other type of transaction at price $ 11.70 per share. | 30 Dec 2022 | 815 | 47,835 (0%) | 0% | 11.7 | 9,539 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2022 | 2,101 | 48,282 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2022 | 2,101 | 63,822 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2022 | 1,520 | 46,181 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2022 | 1,520 | 65,923 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.90 per share. | 09 Oct 2022 | 1,262 | 47,020 (0%) | 0% | 17.9 | 22,590 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2022 | 67,247 | 99,675 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2022 | 33,623 | 79,685 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2022 | 5,866 | 44,129 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2022 | 5,866 | 72,299 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2022 | 4,856 | 48,985 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2022 | 4,856 | 67,443 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.75 per share. | 09 Jul 2022 | 4,324 | 44,661 (0%) | 0% | 17.8 | 76,768 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2022 | 1,520 | 38,263 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2022 | 1,520 | 78,165 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 11,673 | 36,968 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 11,673 | 40,893 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jul 2022 | 4,540 | 32,428 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.53 per share. | 07 Jul 2022 | 4,150 | 36,743 (0%) | 0% | 17.5 | 72,758 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2022 | 1,520 | 46,062 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2022 | 1,520 | 29,496 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.56 per share. | 09 Apr 2022 | 726 | 28,770 (0%) | 0% | 18.6 | 13,476 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2022 | 1,520 | 28,853 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.58 per share. | 09 Jan 2022 | 877 | 27,976 (0%) | 0% | 21.6 | 18,925 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2022 | 520 | 47,582 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.66 per share. | 03 Jan 2022 | 500 | 27,833 (0%) | 0% | 5.7 | 2,830 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 500 | 232,380 | - | - | Stock Option (right to buy) | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 29.07 per share. | 03 Jan 2022 | 500 | 27,333 (0%) | 0% | 29.1 | 14,535 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2021 | 1,520 | 27,623 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2021 | 1,520 | 49,102 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.37 per share. | 09 Oct 2021 | 760 | 26,863 (0%) | 0% | 22.4 | 17,002 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2021 | 48,641 | 48,641 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2021 | 24,320 | 61,344 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2021 | 5,866 | 26,656 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2021 | 5,866 | 55,478 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2021 | 4,856 | 50,622 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2021 | 4,856 | 31,512 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.61 per share. | 09 Jul 2021 | 2,959 | 28,553 (0%) | 0% | 25.6 | 75,783 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.61 per share. | 09 Jul 2021 | 2,450 | 26,103 (0%) | 0% | 25.6 | 62,745 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Other type of transaction at price $ 10.08 per share. | 30 Jun 2021 | 1,053 | 20,790 (0%) | 0% | 10.1 | 10,615 | Common Stock |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2020 | 71,120 | 232,880 | - | - | Stock Option (right to buy) | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2020 | 19,425 | 37,024 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2020 | 5,866 | 17,599 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2020 | 5,866 | 20,039 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.88 per share. | 10 Jul 2020 | 2,056 | 17,983 (0%) | 0% | 6.9 | 14,145 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Other type of transaction at price $ 5.58 per share. | 30 Jun 2020 | 1,691 | 14,173 (0%) | 0% | 5.6 | 9,436 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges